Patents by Inventor Jochem Alsenz

Jochem Alsenz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938136
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: March 26, 2024
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy Mccarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse
  • Patent number: 11491109
    Abstract: The present invention provides novel, solid or liquid pharmaceutical preparations comprising a basic or neutral, low molecular weight active pharmaceutical ingredient and the polymer Eudragit® EPO, optionally together with additional pharmaceutically acceptable excipients. The present preparations are for oral or topical administration.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: November 8, 2022
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Martin Kuentz, Alfred Ross, Wiebke Svea Saal, Nicole Wyttenbach
  • Publication number: 20200323856
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Application
    Filed: November 15, 2019
    Publication date: October 15, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem ALSENZ, Olaf GRASSMANN, Peter KUEHL, Friedrich METZGER, Kathleen Dorothy MCCARTHY, Eduardo Paulo Morawski VIANNA, Marvin Lloyd WOODHOUSE
  • Publication number: 20200206133
    Abstract: The present invention provides novel, solid or liquid pharmaceutical preparations comprising a basic or neutral, low molecular weight active pharmaceutical ingredient and the polymer Eudragit® EPO, optionally together with additional pharmaceutically acceptable excipients. The present preparations are for oral or topical administration.
    Type: Application
    Filed: February 14, 2020
    Publication date: July 2, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem ALSENZ, Martin KUENTZ, Alfred ROSS, Wiebke Svea SAAL, Nicole WYTTENBACH
  • Publication number: 20180289712
    Abstract: The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.
    Type: Application
    Filed: April 17, 2018
    Publication date: October 11, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy McCarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse